NCT00568490 Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
| NCT ID | NCT00568490 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Head and Neck Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 1998-09-01 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 1998-09-01 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to identify and confirm new blood and tissue markers for prognosis and tumor hypoxia. Tumor hypoxia, or the condition of low oxygen in the tumor, has been shown to increase the risk of tumor spread and enhance tumor resistance to the standard treatment of radiation and chemotherapy in head and neck and lung cancers. We have recently identified several proteins or markers in the blood and in tumors (including osteopontin, lysyl oxidase, macrophage inhibiting factor and proteomic technology) in the laboratory that may be able to identify tumors with low oxygen levels or more aggressive behaving tumors.
Eligibility Criteria
Inclusion Criteria: * Histologically confirmed squamous cell carcinoma of the head and neck sites or non-small cell lung cancer, or relatives of patients with histologically confirmed squamous cell carcinoma of the head and neck. * Able to sign a Stanford IRB approved consent form Exclusion criteria: * Refuse or unable to sign an IRB approved consent form. * Refuse to be contacted in the future for follow up.
Contact & Investigator
Eyiwunmi Laseinde
✉ Rad-onc-ccto@lists.stanford.eduQuynh-Thu Le
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT00568490 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Head and Neck Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00568490 currently recruiting?
Yes, NCT00568490 is actively recruiting participants. Contact the research team at Rad-onc-ccto@lists.stanford.edu for enrollment information.
Where is the NCT00568490 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT00568490 clinical trial?
NCT00568490 is sponsored by Stanford University. The principal investigator is Quynh-Thu Le at Stanford University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.